4.7 Article

Modeling and Predicting the Activities of Trans-Acting Splicing Factors with Machine Learning

期刊

CELL SYSTEMS
卷 7, 期 5, 页码 510-+

出版社

CELL PRESS
DOI: 10.1016/j.cels.2018.09.002

关键词

-

资金

  1. National Natural Science Foundation of China [31570823, 31661143031, 31730110]
  2. Science and Technology Commission of Shanghai Municipality [17JC1404900, 18XD1404400]
  3. National Postdoctoral Program for Innovative Talents [BX20180336]
  4. Intramural Research Program of National Institute of Environmental Health Sciences of the National Institutes of Health of USA [Z01 ES102205]
  5. Chinese Scholarship Council Scholarship [201406740040]
  6. CAS Pioneer 100-Talent program
  7. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102205] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Alternative splicing (AS) is generally regulated by trans-splicing factors that specifically bind to cis-elements in pre-mRNAs. The human genome encodes similar to 1,500 RNA binding proteins (RBPs) that potentially regulate AS, yet their functions remain largely unknown. To explore their potential activities, we fused the putative functional domains of RBPs to a sequence-specific RNA-binding domain and systemically analyzed how these engineered factors affect splicing. We discovered that similar to 80% of low-complexity domains in endogenous RBPs displayed distinct context-dependent activities in regulating splicing, indicating that AS is under more extensive regulation than previously expected. We developed a machine learning approach to classify and predict the activities of RBPs based on their sequence compositions and further validated this model using endogenous RBPs and synthetic polypeptides. These results represent a systematic inspection, modeling, prediction, and validation of how RBP sequences affect their activities in controlling splicing, paving the way for de novo engineering of artificial splicing factors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据